Updates are available Correction dated 2023-05-08
Click to view Correction: https://doi.org/10.1038/s41433-023-02493-0
-
Authors
Chang, Yaping https://orcid.org/0000-0002-0549-5087
Phillips, Mark R. https://orcid.org/0000-0003-0923-261X
Guymer, Robyn H. https://orcid.org/0000-0002-9441-4356
Thabane, Lehana https://orcid.org/0000-0003-0355-9734
Bhandari, Mohit https://orcid.org/0000-0001-9608-4808
Chaudhary, Varun https://orcid.org/0000-0002-9988-4146
,
Wykoff, Charles C.
Sivaprasad, Sobha
Kaiser, Peter
Sarraf, David
Bakri, Sophie
Garg, Sunir J.
Singh, Rishi P.
Holz, Frank G.
Wong, Tien Y.
- License Information
-
More Information
Article History
Received: 11 November 2021
Revised: 12 November 2021
Accepted: 16 November 2021
First Online: 5 January 2022
Change Date: 8 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41433-023-02493-0
Competing interests
: YC: Nothing to disclose. MRP: Nothing to disclose. RHG: Advisory boards: Bayer, Novartis, Apellis, Roche, Genentech Inc. LT: Nothing to disclose. MB: Research funds: Pendopharm, Bioventus, Acumed – unrelated to this study. VC: Advisory Board Member: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis – unrelated to this study.
Free to read: This content has been made available to all.
